Ohbe, Hiroyuki
Hachiya, Tsuyoshi http://orcid.org/0000-0002-5274-3266
Yamaji, Taiki http://orcid.org/0000-0002-4799-8782
Nakano, Shiori
Miyamoto, Yoshihisa
Sutoh, Yoichi
Otsuka-Yamasaki, Yayoi
Shimizu, Atsushi
Yasunaga, Hideo
Sawada, Norie
Inoue, Manami
Tsugane, Shoichiro
Iwasaki, Motoki
,
Funding for this research was provided by:
National Cancer Center Research and Development Fund (23-A-31 [toku], 26-A-2, 29-A-4, 2020-J-4)
Grant-in-Aid for Cancer Research from the Ministry of Health, Labour, and Welfare of Japan (19shi-2)
Practical Research for Innovative Cancer Control (JP16ck0106095, JP19ck0106266, JP22ck0106551)
Article History
Received: 28 September 2022
Accepted: 8 December 2022
First Online: 20 December 2022
Declarations
:
: TH is a board member of Genome Analytics Japan Inc.
: The genetic research in the JPHC study, including this study, was approved by the Institutional Review Board of the National Cancer Center, Tokyo, Japan (Approval No.2011–044).
: Before the initiation of genetic research in the JPHC study, we announced its execution via our website and contacted all living blood donors by mail to provide them with the opportunity to opt out of participation in the research.
: Not applicable.